Blood Coagulation Studies and Extracorporeal Circulation in Man

N Thurnherr

doi:10.1055/s-0038-1655073

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1967; 18(03/04): 634-646
DOI: 10.1055/s-0038-1655073

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Blood Coagulation Studies and Extracorporeal Circulation in Man

Authors

N Thurnherr

¹Blood Coagulation and Fibrinolysis Laboratories (Head: Dr. F. Duckert) of the Department of Medicine (Head: Prof. F. Koller) and from the Department of Surgery (Head: Prof. R. Nissen) of the University of Basle (Switzerland)

Abstract

Summary

Blood clotting investigations have been executed in 25 patients who have undergone open heart surgery with extracorporeal circulation. A description of alterations in the activity of blood clotting factors, the fibrinolytic system, prothrombin consumption and platelets during several phases of the operation is given.

Volltext

Referenzen

References
1 Yasargil E. G. Eine einfache Herz-Lungen-Maschine. Thoraxchirurgie 10: 310 1963;
2 Koller F, Loeliger A, Duckert F. Experiments on a new Clotting Factor (Factor VII). Acta haemat. (Basel) 06: 1 1951;
3 Bachmann F, Duckert F, Koller F. The Stuart-Prower-Factor Assay and its Clinical Significance. Thrombos. Diathes. haemorrh. (Stuttgart) 02: 24 1958;
4 Kappeler R. Das Verhalten von Faktor V im Serum unter normalen und pathologischen Bedingungen. Z. klin. Med. 153: 103 1958;
5 Glauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 17: 237 1955;
6 Duckert F. Le Diagnostic des Coagulopathies. Röntgen- u. Lab.-Prax. 13: 652 1960;
7 Nygaard K. K. A Direct Method of Counting Platelets in Oxalated Plasma. Proc. Mayo Clin. 08: 365 1933;
8 Geiger M, Duckert F, Koller F. Quantitative Bestimmung von Faktor VIII und IX bei Blutersippen. 5th Congr. Europ. Soc. Haematol., Freiburg. 1956; 413.
9 Duckert F, Flückiger P, Isenschmidt H, Matter H, Vogel-Meng I, Koller F. A Modification of the Thromboplastin Generation Test. Acta haemat. (Basel) 12: 197 1954;
10 Hunter F. T, Grove-Rasmussen M, Soutter L. A Spectrophotometric Method for Quantitating Hemoglobin in Plasma or Serum. Amer. J. clin. Pathol. 20: 429 1950;
11 Koniakowsky L. Dtsch. med. Rundschau. 1950; 281.
12 Blombäck B, Blombäck M, Olsson P, William-Olsson G, Senning A. Determination of Heparin level of the Blood. Acta chir. scand. Suppl. 245: 259 1959;
13 Milstone A. A factor in normal human blood, which participates in streptococal fibrinolysis. J. Immunol. 42: 109 1941;
14 Perkins H. A, Rolfs M. R, Torg B. Assay of Blood Coagulation Factors in Heparinized Blood. Thrombos. Diathes. haemorrh. (Stuttg) 11: 254 1964;
15 Hougie G. Anticoagulant action of Protamin Sulphate. Proc. Soc. exp. Biol. (N. Y) 98: 130 1958;
16 Von Kaulla K. N. Spontaneous Anticoagulants in Surgery. Acta haemat. (Basel) 24: 135 1960;
17 Phillips L. L, Malm J. R, Deterling R. A. Coagulation Defects Following Extracorporeal Circulation. Ann. Surg 157: 317 1963;
18 Von Kaulla K. N, Swan H. L. Clotting Deviations in Man during Cardiac Bypass, Fibrinolysin and Circulatory Anticoagulant. J. thorac. Surg 36: 519 1958;
19 Schmidt P. J, Peden J. G, Brecher A, Baranovsky A. Thrombocytopenia and Bleeding Tendency after Extracorporeal Circulation. New. Engl. J. Med 265: 1181 1961;
20 Kendall A. G, Loewenstein L. Alterations in Blood Coagulation and Hemostasis during Extracorporeal Circulation. Part I -f- Part II. Canad. med. Ass. J 87: 786-859 1962;
21 Perkins A. H, Harkins G, Gerbode F, Rolfs M. R, Acra D. J. Comparison of Effects of Protamin and Polybrene with Special Emphasis on the Factor VIII Deficiency Induced. J. clin. Invest 40: 1421 1961;
22 Brögli H. Der Mechanismus des sogenannten »Heparin-Rebound« nach extrakorporellem Kreislauf. Thrombos. Diathes. haemorrh. (Stuttg) 13: 401 1965;
23 Loeliger A. Diskussion zum Vortrag von Marx, R., H. Borst, über Heparinisierung von Patienten und Neutralisierung mit Protaminsulfat. Thoraxchirurgie 09: 84 1962;
24 Senning A. Plasma-Heparin Concentration in Extracorporeal Circulation. Acta chir. scand 117: 55 1959;
25 Perkins H. A, Osborne J. J, Hurt R, Gerbode F. Neutralization of Heparin in vivo with Protamine; a Simple Method of Estimating the Required Dose. J. Lab. clin. Med 48: 223 1956;
26 Hawksley M. De-Heparinization of Blood after Cardiopulmonary Bypass. Lancet I: 563 1966;
27 Andersen H. N, Mendelow M, Murray N. A comparative study of heparin neutralization and the danger of blood clotting abnormalities with protamin and polybren. J. thorac. Surg 39: 613 1960;
28 Long D. M, Sanchez L, Varco R. The use of low molecular dextran and albumin as plasmaexpanders. Surgery 50: 12 1961;
29 Wright J. S, Osborn J. J, Perkins H. A, Gerbode F. Heparin Levels During and After Hypothermic Perfusion. J. cardiovasc. Surg 05: 244 1964;
30 Anderssen M. N, Mendelow M. Fibrinolysis During and After ECC. Arch. Surgery 86: 649 1963;
31 Holemans R, Vermylen C, Verstraete M. Disappearance of Factor V Activity after Incubation of Plasma with Heparin or Heparinoids. Thrombos. Diathes. haemorrh. (Stuttg) 04: 303 1960;
32 Salzman E. W. Blood Platelets and Extracorporeal Circulation. Transfusion 03: 274 1963;